全文获取类型
收费全文 | 1744篇 |
免费 | 127篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 40篇 |
妇产科学 | 33篇 |
基础医学 | 253篇 |
口腔科学 | 35篇 |
临床医学 | 236篇 |
内科学 | 358篇 |
皮肤病学 | 18篇 |
神经病学 | 222篇 |
特种医学 | 53篇 |
外科学 | 172篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 198篇 |
眼科学 | 12篇 |
药学 | 156篇 |
中国医学 | 4篇 |
肿瘤学 | 71篇 |
出版年
2023年 | 14篇 |
2022年 | 21篇 |
2021年 | 31篇 |
2020年 | 31篇 |
2019年 | 49篇 |
2018年 | 45篇 |
2017年 | 59篇 |
2016年 | 53篇 |
2015年 | 51篇 |
2014年 | 51篇 |
2013年 | 80篇 |
2012年 | 120篇 |
2011年 | 114篇 |
2010年 | 63篇 |
2009年 | 63篇 |
2008年 | 98篇 |
2007年 | 107篇 |
2006年 | 102篇 |
2005年 | 104篇 |
2004年 | 87篇 |
2003年 | 80篇 |
2002年 | 78篇 |
2001年 | 16篇 |
2000年 | 25篇 |
1999年 | 12篇 |
1998年 | 15篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 11篇 |
1992年 | 17篇 |
1991年 | 19篇 |
1990年 | 19篇 |
1989年 | 20篇 |
1988年 | 16篇 |
1987年 | 17篇 |
1986年 | 20篇 |
1985年 | 19篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1981年 | 4篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1970年 | 4篇 |
1969年 | 7篇 |
1967年 | 5篇 |
1966年 | 6篇 |
排序方式: 共有1873条查询结果,搜索用时 15 毫秒
31.
Hurrah for the increasing longevity: feasible strategies to counteract age‐related loss of skeletal muscle mass 下载免费PDF全文
32.
Expression of hypoxia‐inducible factor‐1α and hepatocyte growth factor in development of fibrosis in the transplanted kidney 下载免费PDF全文
Terese Kellenberger Niels Marcussen Jens R. Nyengaard Lise Wogensen Bente Jespersen 《Transplant international》2015,28(2):180-190
Late renal graft loss is associated with interstitial fibrosis. Hypoxia‐inducible factor‐1α (HIF‐1α) is thought to facilitate fibrosis through interaction with TGF‐β1, while hepatocyte growth factor (HGF) may act antifibrotic in the kidney allograft. The aim of this study was to investigate the expression of HIF‐1α and HGF in protocol biopsies as possible prognostic biomarkers for renal fibrosis. Thirty‐nine renal transplant recipients were included in the study. Protocol biopsies performed 1 and 2 years after transplantation were used for immunohistochemistry analysis. The correlation between HIF‐1α/HGF and the Banff score was analysed. In addition, progression in renal fibrosis and graft survival among recipients with high or low expression of HIF‐1α/HGF after transplantation was compared. There was no significant correlation between fibrosis and the HIF‐1α expression 1 and 2 years after transplantation, but an inverse significant correlation between the HGF expression and the fibrosis score 1 year after transplantation was shown. Even when adjusting for human leucocyte antigen mismatches, there was a significant relationship between fibrosis and HGF expression. Graft survival was not significantly correlated to HIF‐1α or HGF at 1 year, although the trend was towards better graft survival with high HGF. HGF may have antifibrotic effects in human renal transplants. (Central.Denmark.Region.Committee number: 1‐10‐72‐318‐13) 相似文献
33.
Children hospitalised with bronchiolitis in the first year of life have a lower quality of life nine months later 下载免费PDF全文
34.
Sanne Jespersen Bo Langhoff Hnge Candida Medina David da Silva T Faustino Gomes Correira Alex Lund Laursen Christian Erikstrup Lars
stergaard Christian Wejse 《Journal of the International AIDS Society》2015,18(1)
Introduction
With more people receiving antiretroviral treatment (ART), the need to detect treatment failure and switch to second-line ART has also increased. We assessed CD4 cell counts (as a marker of treatment failure), determined the rate of switching to second-line treatment and evaluated mortality related to treatment failure among HIV-infected patients in Guinea-Bissau.Methods
In this retrospective cohort study, adult patients infected with HIV-1 receiving ≥6 months of ART at an HIV clinic in Bissau were included from June 2005 to July 2014 and followed until January 2015. Treatment failure was defined as 1) a fall in CD4 count to baseline (or below) or 2) CD4 levels persistently below 100 cells/µL after ≥6 months of ART. Cox hazard models, with time since six months of ART as the time-varying coefficient, were used to estimate the hazard ratio for death and loss to follow-up.Results
We assessed 1,591 HIV-1-infected patients for immunological treatment failure. Treatment failure could not be determined in 594 patients (37.3%) because of missing CD4 cell counts. Among the remaining 997 patients, 393 (39.4%) experienced failure. Only 39 patients (9.9%) with failure were switched from first- to second-line ART. The overall switching rate was 3.1 per 100 person-years. Mortality rate was higher in patients with than without treatment failure, with adjusted hazard rate ratios (HRRs) 10.0 (95% CI: 0.9–107.8), 7.6 (95% CI: 1.6–35.5) and 3.1 (95% CI: 1.5–6.3) in the first, second and following years, respectively. During the first year of follow-up, patients experiencing treatment failure had a higher risk of being lost to follow-up than patients not experiencing treatment failure (adjusted HRR 4.4; 95% CI: 1.7–11.8).Conclusions
We found a high rate of treatment failure, an alarmingly high number of patients for whom treatment failure could not be assessed, and a low rate of switching to a second-line therapy. These factors could lead to an increased risk of resistance development and excess mortality. 相似文献35.
Dominik Linz Eva Hesselkilde Rayed Kutieleh Thomas Jespersen Rikke Buhl Prashanthan Sanders 《Journal of cardiovascular electrophysiology》2020,31(5):1211-1212
Atrial fibrillation is triggered by the pulmonary veins in humans. Although atrial fibrillation is known to occur in other species, the mechanisms of disease in these are not known. Here we present evidence for pulmonary vein triggers in the horse, where 3D HD Grid mapping was undertaken in the conscious state in the absence of fluoroscopy. 相似文献
36.
Else-Marie Bladbjerg Thomas M. Larsen Anette Due Jørgen Jespersen Steen Stender Arne Astrup 《Thrombosis research》2014
Diet is important in the prevention of cardiovascular disease, and it has been suggested that a high-MUFA diet is more cardioprotective than a low-fat diet. We hypothesised that the postprandial thrombotic risk profile is improved most favourably by a high-MUFA diet compared with a low-fat diet. This was tested in a parallel intervention trial on overweight individuals (aged 28.4 (SD 4.7) years) randomly assigned to a MUFA-diet (35-45% of energy as fat; > 20% as MUFA, n = 21) or a low-fat (LF) diet (20-30% of energy as fat, n = 22) for 6 months after a weight loss of ~ 10%. All foods were provided free of charge from a purpose-built supermarket. Meal tests designed after the same principles were performed before and after the dietary intervention, and blood samples were collected at 8.00 h (fasting), 12.00 h, and 18.00 h and analysed for factor VII coagulant activity (FVII:C), activated FVII, fibrinogen, prothrombin fragment 1 + 2 (F1 + 2), D-dimer, plasminogen activator inhibitor (PAI:Ag), and thrombin activatable fibrinolysis inhibitor. There were significant postprandial increases in F1 + 2 and D-dimer before and after dietary intervention, with significantly lower values after 6 months. No significant differences were observed between the postprandial changes induced by the two diets. The postprandial decrease in FVII:C and PAI:Ag did not differ before and after intervention, irrespective of the diets. Our findings suggest postprandial coagulation activation in overweight subjects with more pronounced acute than long-term effects. We observed similar effects of the MUFA diet and the LF diet on the postprandial prothrombotic risk profile. 相似文献
37.
Romundstad LB 《Lancet》2012,379(9815):497-498
38.
39.
40.